• Provide experienced team for clinical pharmacology and pharmacometrics to start up and mid-size pharma companies  

  • Diversity in therapeutic area experience

  • Built-in differentiation strategies based on generating data as part of routine development studies

  • Reduce development costs and time 

Development Program Services:

  • Slim and adequate studies at the right time to support regulatory interactions in different phases of development

  • Informed and data driven dose selection to optimize efficacy and minimize safety issues

  • ​Product differentiation strategies

  • Clinical pharmacology 

  • Pharmacometrics

  • Translational medicine


Business Development:

  • Due diligence whether you are assessing to buy or seeking to sell an asset

  • Assessment of risks and technical probability of success  

OUR KEY BENEFITS FOR DRUG DEVELOPMENT NEEDS:

FOCUS

OUR COMPANY AT A GLANCE

Regulatory Interactions:

  • Regulatory Briefing Books

  • Regulatory questions and responses

  • IND preparations

  • End of Phase I/II meetings

  • pre-NDA meetings

  • NDA preparations and filing

  • FDA, EMA and PMDA interactions


Other:

  • Drug Safety Monitoring Boards

  • Scientific Advisories

  • Publications and presentations

​Inncelerex was founded by Dr Parviz Ghahramani who attracted other experienced talents in drug development and built a team of experts in clinical pharmacology, pharmacometrics and drug development. 


The company thrives to provide a prepared team of scientists who can provide instant support where and when needed in development programs without the need for a pharmacompany to employ a full department of scientists.